ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.098,09
-0,50%
S&P 500
5.277,51
0,80%
US Dollar vs BRL
5,2459
0,00%
Bitcoin
67.580,62
0,15%
Brent Oil
81,295
0,00%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Cellular Biomedicine Group Inc (CBMG)

  7. Cellular Biomedicine Group Inc (CBMG) Notícias

CBMG

Cellular Biomedicine (CBMG)

Cellular Biomedicine Group Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CBMG
DataHoraFonteTítuloCódigoCompanhia
03/03/202116:40Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:CBMGCellular Biomedicine Group Inc
26/02/202108:14Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CBMGCellular Biomedicine Group Inc
22/02/202108:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CBMGCellular Biomedicine Group Inc
19/02/202118:11Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:CBMGCellular Biomedicine Group Inc
19/02/202117:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CBMGCellular Biomedicine Group Inc
19/02/202117:11Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CBMGCellular Biomedicine Group Inc
19/02/202117:10Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CBMGCellular Biomedicine Group Inc
19/02/202117:07Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:CBMGCellular Biomedicine Group Inc
19/02/202117:05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBMGCellular Biomedicine Group Inc
19/02/202116:55PR Newswire (US)Cellular Biomedicine Group, Inc. Announces Completion of MergerNASDAQ:CBMGCellular Biomedicine Group Inc
08/02/202118:19PR Newswire (US)Cellular Biomedicine Group, Inc. Stockholders Approve MergerNASDAQ:CBMGCellular Biomedicine Group Inc
01/02/202116:50Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CBMGCellular Biomedicine Group Inc
28/01/202118:30PR Newswire (US)Leading Proxy Advisory Firms Glass Lewis and ISS Recommend Cellular Biomedicine Group Stockholders Vote FOR Proposed MergerNASDAQ:CBMGCellular Biomedicine Group Inc
26/01/202119:21Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CBMGCellular Biomedicine Group Inc
29/12/202018:11Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:CBMGCellular Biomedicine Group Inc
08/12/202008:42Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:CBMGCellular Biomedicine Group Inc
04/12/202009:35PR Newswire (US)Cellular Biomedicine Group Announces Data to be Presented at 2020 ASH Annual MeetingNASDAQ:CBMGCellular Biomedicine Group Inc
09/11/202019:24PR Newswire (US)Cellular Biomedicine Group Reports Q3 2020 Financial Results and Business HighlightsNASDAQ:CBMGCellular Biomedicine Group Inc
09/11/202018:26Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CBMGCellular Biomedicine Group Inc
26/08/202010:00PR Newswire (US)Cellular Biomedicine Group to Present at Chinese Biopharmaceutical Association-USA Annual ConferenceNASDAQ:CBMGCellular Biomedicine Group Inc
14/08/202017:34Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CBMGCellular Biomedicine Group Inc
14/08/202017:33Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:CBMGCellular Biomedicine Group Inc
13/08/202016:25Business WireALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Cellular Biomedicine Group, Inc.NASDAQ:CBMGCellular Biomedicine Group Inc
12/08/202017:30PR Newswire (US)Cellular Biomedicine Group (CBMG) Reports Q2, H1 2020 Financial Results and Business HighlightsNASDAQ:CBMGCellular Biomedicine Group Inc
12/08/202007:30PR Newswire (US)Cellular Biomedicine Group (CBMG) Enters Into Definitive Merger Agreement; Transaction Would Result In Company Going PrivateNASDAQ:CBMGCellular Biomedicine Group Inc
10/08/202017:17Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:CBMGCellular Biomedicine Group Inc
13/07/202008:29PR Newswire (US)Cellular Biomedicine Group (CBMG) Hosts R&D Showcase and Provides Updates to Clinical ProgramsNASDAQ:CBMGCellular Biomedicine Group Inc
30/06/202017:15PR Newswire (US)Cellular Biomedicine Group (CBMG) to Host Investor R&D Showcase Highlighting Updates to Clinical ProgramsNASDAQ:CBMGCellular Biomedicine Group Inc
29/06/202009:55PR Newswire (US)Cellular Biomedicine Group (CBMG) Announces Results of 2020 Annual Meeting of StockholdersNASDAQ:CBMGCellular Biomedicine Group Inc
22/06/202010:00PR Newswire (US)Cellular Biomedicine Group (CBMG) Presents Poster of TCRs Targeting AFP-Positive Liver Cancer at AACR Annual MeetingNASDAQ:CBMGCellular Biomedicine Group Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:CBMG

Seu Histórico Recente

TSXV
SOU
Southern Energy
BIT
P1WAC1
NLBNPIT1WAC1 20240920 1.06
BOV
WEGE3
WEG ON
BIT
ELCR
Lyxor Msci Future Mob Es...
BIT
P1XA11
NLBNPIT1XA11 20241220 60
BIT
UB261P
UniCredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados